184 related articles for article (PubMed ID: 27382830)
21. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
22. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
23. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.
Hanley GE; Mintzes B
BMC Pregnancy Childbirth; 2014 Jul; 14():242. PubMed ID: 25048574
[TBL] [Abstract][Full Text] [Related]
24. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
25. Pediatric use of prescribed melatonin in Sweden 2006-2017: a register based study.
Kimland EE; Bardage C; Collin J; Järleborg A; Ljung R; Iliadou AN
Eur Child Adolesc Psychiatry; 2021 Sep; 30(9):1339-1350. PubMed ID: 32699990
[TBL] [Abstract][Full Text] [Related]
26. [Psychopharmacological drugs in childhood (author's transl)].
Groh C; Rosenmayr F
Padiatr Padol; 1982; 17(2):319-28. PubMed ID: 7099685
[TBL] [Abstract][Full Text] [Related]
27. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
[TBL] [Abstract][Full Text] [Related]
28. Polypharmacy with antidepressants in children and adolescents.
Díaz-Caneja CM; Espliego A; Parellada M; Arango C; Moreno C
Int J Neuropsychopharmacol; 2014 Jul; 17(7):1063-82. PubMed ID: 23190624
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
McDaniel KD
Clin Pediatr (Phila); 1986 Feb; 25(2):65-71. PubMed ID: 2417773
[TBL] [Abstract][Full Text] [Related]
30. [Therapy with psychotropic drugs in child and adolescent psychiatry. Possibilities and limitations].
du Bois R
Dtsch Krankenpflegez; 1990 Apr; 43(4):266-9. PubMed ID: 2116274
[No Abstract] [Full Text] [Related]
31. Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
Fullerton CA; Epstein AM; Frank RG; Normand SL; Fu CX; McGuire TG
Psychiatr Serv; 2012 Feb; 63(2):115-21. PubMed ID: 22302327
[TBL] [Abstract][Full Text] [Related]
32. Melatonin for sleep problems in children with neurodevelopmental disorders.
Drug Ther Bull; 2015 Oct; 53(10):117-20. PubMed ID: 26471270
[TBL] [Abstract][Full Text] [Related]
33. The use of psychotropic drugs in epilepsy: what every neurologist should know.
Kanner AM
Semin Neurol; 2008 Jul; 28(3):379-88. PubMed ID: 18777484
[TBL] [Abstract][Full Text] [Related]
34. Sleep-promoting medications in children: physician prescribing habits in Southwestern Ontario, Canada.
Bock DE; Roach-Fox E; Seabrook JA; Rieder MJ; Matsui D
Sleep Med; 2016 Jan; 17():52-6. PubMed ID: 26847974
[TBL] [Abstract][Full Text] [Related]
35. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
[No Abstract] [Full Text] [Related]
36. Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
Hornig M
J Clin Psychiatry; 1998; 59 Suppl 7():69-75. PubMed ID: 9680055
[TBL] [Abstract][Full Text] [Related]
37. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
[No Abstract] [Full Text] [Related]
38. Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy.
Karouni M; Henning O; Larsson PG; Johannessen SI; Johannessen Landmark C
Epilepsy Behav; 2013 Oct; 29(1):77-81. PubMed ID: 23939032
[TBL] [Abstract][Full Text] [Related]
39. Management of Adverse Effects of Psychotropic Medications.
Romba C; Perez-Reisler M
Pediatr Ann; 2020 Oct; 49(10):e431-e435. PubMed ID: 33034658
[TBL] [Abstract][Full Text] [Related]
40. Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care.
Boles M; Lynch FL; DeBar LL
J Child Adolesc Psychopharmacol; 2001; 11(1):43-52. PubMed ID: 11322744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
